DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 4538--------------------------------------------------
       (Abst.) Safety of high-efficacy therapies in older people with M
       S...
       By: agate Date: September 2, 2024, 4:15 pm
       ---------------------------------------------------------
       [font=ElsevierGulliver][/font][font=ElsevierGulliver][/size]
       From PubMed (September 2, 2024)--"Safety of high-efficacy
       therapies in older people with multiple sclerosis: A real-world
       evidence study":
  HTML https://pubmed.ncbi.nlm.nih.gov/39216455/
       In the abstract (link above), there is a misprint. The first
       three sentences of the  "Results" section should be:
       RESULTS: In the present study, 882 pwMS were included. Of these
       pwMS, 141 (15.9 %) were 50 years old or more (median: 56, IQR:
       11). Of this group, 47 (33.3 %) were under HETs (G1). [/font]
       [font=ElsevierGulliver][/size][/font]
       *****************************************************